The Tribunal found that Robert Stannard committed an Anti-Doping Rule Violation (ADRV) for use of a prohibited substance or a prohibited method due to unexplained abnormalities in his Biological Passport* in 2018 and 2019. These abnormalities were thoroughly followed up and investigated by the ITA after the UCI delegated its operational anti-doping program to the independent organisation in the beginning of 2021. As a consequence, the Tribunal has imposed a four-year period of suspension on the rider as well as a monetary fine corresponding to 70% of his average annual salary in 2018 and 2019.
In accordance with the applicable rules, i.e. the World Anti-Doping Code and the UCI Anti-Doping Rules, the Tribunal decided that the period of suspension shall start on 17 August 2018, i.e. the day of the appearance of the first abnormality, taking into account the delay with which the rider’s abnormalities were communicated to the UCI.
The decision is not final as it can be appealed before the Court of Arbitration for Sport (CAS) by the rider, his National Federation and National Anti-Doping Agency, the UCI and the World Anti-Doping Agency (WADA) within one month. The decision will be published on the UCI website once final.
The ITA will not comment further on the matter.
The International Testing Agency (ITA) confirms that samples it collected out-of-competition (OOC) on 27 October 2022 from Ukrainian weightlifters Ruslan Kozhakin and Bohdan Taranenko returned an Adverse Analytical Finding (AAF)[1] for the presence of the prohibited substance trimetazidine, a non-specified prohibited substance, according to the prohibited list of the World Anti-Doping Agency (WADA).
Following the results management process, the ITA submitted the matters for adjudication to the Anti-Doping Division of the Court of Arbitration for Sport (CAS ADD). On 24 May 2024, CAS ADD issued its final decision confirming that the athletes had committed Anti-Doping Rule Violations (ADRVs) and sanctioned Ruslan Kozhakin and Bohdan Taranenko each with a period of ineligibility of 48 months from 2 December 2022 and a disqualification of their competitive results from 27 October 2022 onwards. The athletes have also been granted a 6-month credit for providing Substantial Assistance[2] to the Ukrainian National Anti-Doping Organization.
Additionally, an OOC sample collected by the ITA from Alina Marushchak on 10 March 2023 returned an AAF for the presence of the prohibited substance hydrochlorothiazide, a specified prohibited substance, according to the prohibited list.
The case was resolved via an agreement on consequences pursuant to article 8.3.1 of the anti-doping rules of the International Weightlifting Federation (IWF ADR, and the equivalent provision in the World Anti-Doping Code). The athlete accepted a period of ineligibility of two years from 13 April 2023 and the disqualification of all competitive results from 10 March 2023 onwards.
Given that the three athletes from the Ukrainian Weightlifting Federation have committed ADRVs within a 12-month period, this has triggered the Article 12.3[3] of the IWF ADR and provisions of the IWF Olympic Qualification System (OQS). As a result, the matter will now be submitted to IWF’s Independent Member Federation Sanctioning Panel to impose appropriate consequences.
No further comments will be made on this case.
THE INTERNATIONAL TESTING AGENCY (ITA) REPORTS THAT THE INDIAN BOXER PARVEEN HOODA HAS BEEN SANCTIONED WITH A 22-MONTH PERIOD OF INELIGIBILITY FOR A COMBINATION OF THREE WHEREABOUTS FAILURES WITHIN A TWELVE-MONTH PERIOD.
The ITA confirms that boxer Parveen Hooda has been suspended for a 22-month period, effective until 16 July 2025, after committing three whereabouts failures within a twelve-month period as defined in article 2.4 of the International Boxing Association anti-doping rules (IBA ADR)1.
The case was resolved via an agreement on consequences pursuant to article 8.3.1 of the IBA ADR, and equivalent provision in the World Anti-Doping Code.
In addition to the period of Ineligibility, the athlete’s results obtained between 11 December 2022 until 17 May 2024 are disqualified.
Ms Hooda is thus ineligible to participate in the Olympic Games Paris 2024 and the matter related to her Olympic quota will be treated in accordance with the Paris 2024 Boxing Qualification System2, which does not fall under the ITA’s remits.
Insofar as the World Anti-Doping Agency (WADA) and the National Anti-Doping Agency of India (NADA) have a right to appeal against the sanction before the appeals division of the Court of Arbitration for Sport, there will be no further comments.
The ITA confirms that Hungarian fencer Anna Kun has been notified of a potential Anti-Doping Rule Violation pursuant to article 2.4 of the FIE Anti-Doping Rules (“FIE ADR”), namely the occurrence of three Whereabouts Failures within a twelve month period1.
The case will be referred to the FIE Doping Disciplinary Tribunal in charge of hearings and adjudication of anti-doping matters.
Pursuant to the FIE ADR and World Anti-Doping Code, Anna Kun is not subject to a mandatory provisional suspension pending the resolution of the matter.
Given that the case is underway, there will be no further comments during the ongoing proceedings.
As a follow-up to the ITA’s and the World Anti-Doping Agency’s (WADA) investigations on doping in the sport of weightlifting until 2018, the ITA had received WADA’s case file pertaining to “Operation Arrow”. This investigation focused on the practice of urine substitution at the point of collection. After a thorough assessment of the information and evidence the ITA decided to assert an anti-doping rule violation (ADRV) for sample swapping against athlete Nijat Rahimov (Kazakhstan). The urine substitution (Article 2.2 of the IWF Anti-Doping Rules) occurred on four occasions over a period of time in 2016, in preparation for the Olympic Games Rio 2016.
On 22 March 2022, the anti-doping division of the Court of Arbitration for Sport (CAS ADD) sanctioned the athlete with 8 years of ineligibility and the disqualification of all results obtained from 15 March 2016.
On 12 April 2022, the athlete filed an appeal before CAS. A hearing took place on 22 September 2022 at the CAS headquarters in which the ITA represented the International Weightlifting Federation (IWF). After hearing the parties and considering the written submissions and evidence, CAS confirmed that the athlete had committed several ADRVs for the of use of a prohibited method (urine substitution) in accordance with Article 2.2 of the IWF Anti-Doping Rules.
In its decision, CAS notably held that this matter was “a clear case of cheating by an athlete seeking to avoid anti-doping testing” and that “this is the kind of cheating the anti-doping rules are designed to prevent”.
Since this was the athlete’s second ADRV, CAS confirmed that Nijat Rahimov should be sanctioned with 8 years of ineligibility. The disqualification of all results obtained by the athlete from 15 March 2016 (date of the first evidence of urine substitution) until the provisional suspension imposed on 18 January 2021, which includes the gold medal obtained at the Olympic Games Rio 2016 (Men’s 77 kg), was also confirmed.
The ITA will not comment further on this case.
The International Testing Agency (ITA), mandated by the Olympic Counsel of Asia (OCA) to independently handle areas of the anti-doping program at the Asian Games Hangzhou 2022, including results management, reports that a sample collected from boxing athlete Mohammad Khaibar Nooristani (Afghanistan) has returned an Adverse Analytical Finding¹ for the non-specified prohibited substances (i) 19-norandrosterone and (ii) Clostebol metabolite 4-chloro-3α-hydroxy-androst-4-en-17-one according to the Prohibited List of the World Anti-Doping Agency (WADA).
The sample was collected by the ITA at the Asian Games Hangzhou 2022 during an out-of-competition anti-doping control performed on 21 September 2023.
The athlete has been informed of the case and has been provisionally suspended with immediate effect. He has the right to request the analysis of the B-sample.
The matter will thereafter be referred to the Anti-Doping Division of the Court of Arbitration for Sport (CAS ADD) for adjudication under the OCA Anti-Doping Rules.
Given that the case is underway, there will be no further comments during the ongoing proceeding.
WITH THE GOAL OF PROVIDING COMPREHENSIVE AND QUALITATIVE FOUNDATIONAL TRAINING ON A GLOBAL SCALE TO PERSONNEL OF ANTI-DOPING ORGANISATIONS AND INDIVIDUALS SEEKING TO ESTABLISH THEMSELVES AS DOPING CONTROL OFFICERS (DCOS), THE INTERNATIONAL TESTING AGENCY (ITA) RECENTLY CONDUCTED ITS FIRST ITA DCO FOUNDATION TRAINING IN ASIA. THE THREE-DAY FACE-TO-FACE TRAINING WAS CONDUCTED AT THE SHANGHAI UNIVERSITY OF SPORTS (SUS), ITA’S FIRST EVER ACADEMIC CENTRE.
Equipping DCOs for Effective Anti-Doping Operations
The ITA’s DCO Foundation Training which was held on 10-12 July at the SUS is an intensive three-day program designed to equip participants with the knowledge, skills, and ethical insights needed to conduct effective anti-doping operations. The training covers a wide array of topics, including an introduction to anti-doping, DCO roles in testing procedures, sample collection techniques, athlete communication, and the legal and ethical dimensions of anti-doping efforts. Role play, the practical handling of doping control kits, interactions and discussions supported the learning process.
The main aim of the training is not only to prepare the participants for their first doping control missions as DCOs, but also to harmonise testing processes worldwide and emphasise the importance of maintaining high ethical standards throughout their work. The ITA aims to instill a deep appreciation for the significance of anti-doping endeavors, inspiring these professionals to be advocates for clean sport.
SUS: A Hub for Anti-Doping Education
Selecting the Shanghai University of Sports as the venue for the ITA DCO Foundation Training underscores the institution’s commitment to sports education and research. As a recognised ITA Academic Centre, SUS provides an ideal setting for a training program that focuses on upholding the values of sports. The collaboration with SUS also allowed the ITA to hold the training for the first time on the Asian continent, easing access for participants from Asian National and Regional Anti-Doping Organisations, sports bodies and interested individuals living on the continent.
Global Participation for Unified Action
The ITA DCO Foundation Training in Shanghai was also held with the support of the Chinese Anti-Doping Agency (CHINADA) and saw participation from a diverse group of thirty course graduates representing various countries: China, HongKong, Chinese Taipei, South Africa, Indonesia, Kyrgyzstan, Greece, Malaysia, Mauritius, New Zealand and the United States.
This global participation showcases the collaborative efforts being made by the ITA to promote quality testing across the globe and uphold the principles of fair play and clean sport. As the thirty course graduates return to their respective regions and countries armed with newfound knowledge and an ITA certification, they may apply to become a DCO with their respective national anti-doping agency or any other anti-doping organisation and hopefully join the clean sport community for many years to come.
The training is delivered with the support of Berlinger Special AG, who also provides the sample collection equipment for the training.
The next ITA DCO Foundation Training will be held in Lausanne, Switzerland, on 25-27 October, more information can be found here.
THE INTERNATIONAL TESTING AGENCY (ITA) REPORTS THAT THE ARGENTINIAN GYMNAST MARTINA DOMINICI HAS ACCEPTED A THREE-YEAR PERIOD OF INELIGIBILITY AFTER TESTING POSITIVE FOR TWO ANABOLIC ANDROGENIC STEROIDS.
THE INTERNATIONAL TESTING AGENCY (ITA), LEADING AN INDEPENDENT ANTI-DOPING PROGRAM FOR THE INTERNATIONAL OLYMPIC COMMITTEE (IOC) AND THE UNITED WORLD WRESTLING UNION (UWW), ASSERTS AN APPARENT ANTI-DOPING RULE VIOLATION (ADRV) AGAINST KAZAKSTAN WRESTLER ASKHAT DILMUKHAMEDOV. THIS IS THE FIRST APPARENT ADRV RESULTING FROM A TARGETED DOPING CONTROL CARRIED OUT BY THE ITA DURING IOC’S EXTENDED TESTING AUTHORITY IN THE LEAD-UP TO THE OLYMPIC GAMES TOKYO 2020.
THE INTERNATIONAL TESTING AGENCY (ITA) CONFIRMS THE IMPOSITION OF SANCTIONS BY THE INTERNATIONAL WEIGHTLIFTING FEDERATIONS’ (IWF’S) MEMBER FEDERATION INDEPENDENT SANCTIONING PANEL AGAINST THE VIETNAMESE AND COLOMBIAN WEIGHTLIFTING FEDERATIONS UPON REFERRAL BY THE ITA. THE ITA WILL ALSO REFER THE TURKISH WEIGHTLIFTING FEDERATION BEFORE THE IWF INDEPENDENT SANCTION PANEL FOR MULTIPLE VIOLATIONS.
Published Friday, 03 August 2018.
The International Testing Agency (ITA) confirms as follows:
- A sample collected in-competition (IC) by the ITA from Turkish weightlifter Hakan Sukru Kurnaz returned an Adverse Analytical Finding (AAF)[1] for the presence of methasterone metabolite, a non-specified prohibited substance, according to the prohibited list of the World Anti-Doping Agency (WADA). The athlete was able to establish that the presence of methasterone metabolite in his sample was through use of a contaminated supplement. The case was resolved via an agreement on consequences pursuant to article 8.3.1 of the anti-doping rules of the International Weightlifting Federation (IWF ADR, and the equivalent provision in the World Anti-Doping Code). The athlete accepted a period of ineligibility of 22 months from 26 May 2023 and the disqualification of all competitive results from 21 April 2023 onwards.
- A sample collected IC by the ITA from Turkish weightlifter Pelinsu Bayav returned AAFs for the presence of methasterone, stanozolol metabolites, methyltestosterone metabolite and clenbuterol, non-specified prohibited substances, according to the prohibited list of WADA. The athlete admitted to the violation under Article 10.8.1 IWF ADR and the case was resolved via an agreement on consequences pursuant to article 8.3.1 IWF ADR. The athlete accepted a period of ineligibility of 36 months from 26 May 2023 and the disqualification of all competitive results from 15 April 2023 onwards.
- Turkish weightlifter Dogan Donen has committed an anti-doping rule violation under article 2.4 of the IWF ADR namely the occurrence of three Whereabouts Failures within a 12-month period.[2] The athlete accepted the consequences of the violation, and the ITA issued a sanctioning decision under Article 8.3.3 of the IWF ADR imposing a period of ineligibility of 24 months from 8 April 2024 and the disqualification of all competitive results from 1 April 2023 onwards.
Given that three athletes from the Turkish Weightlifting Federation have committed anti-doping rule violations (ADRVs) within a 12-month period, this has triggered the Article 12.3[3] of the IWF ADR and provisions of the IWF Olympic Qualification System (OQS). As a result, the matter has been submitted to IWF’s Independent Member Federation Sanctioning Panel to impose appropriate consequences.
No further comments will be made on these cases.
The Tribunal found Miguel Ángel López guilty of an anti-doping rule violation (ADRV) for use and possession of a prohibited substance (Menotropin)*, concomitantly with the 2022 Giro d’Italia, and has imposed a four-year suspension on the rider.
In accordance with the World Anti-Doping Code and the UCI Anti-Doping Rules, the period of suspension started on 25 July 2023 and will remain in force until 24 July 2027.
The disciplinary proceeding was initiated following an investigation conducted by the ITA based on evidence obtained from the Spanish Guardia Civil and the Spanish Anti-Doping Organisation (CELAD) in the so-called Operation “Ilex” concerning Dr Marcos Maynar. This valuable collaboration demonstrates the importance of intelligence-sharing between the ITA, National Anti-Doping Organisations and law enforcement authorities.
In line with the Procedural Rules of the UCI Tribunal, the decision will be published on the UCI website. The decision may be appealed before the Court of Arbitration for Sport (CAS) within one month.
The ITA will not comment further on the matter.
As a reminder, the UCI delegated the operational activities of its anti-doping programme to the International Testing Agency (ITA) in January 2021. Since then, cycling’s clean sport efforts have been led by the ITA Cycling Unit, which is dedicated specifically to all disciplines of cycling. The UCI and the ITA are bound by a service agreement which guarantees that the ITA operates in an independent manner.
Please find the UCI statement on the matter here.
THE ITA, ON BEHALF OF IRONMAN, HEREBY REPORTS THAT ITALIAN ATHLETE VINCENZO TOMASELLO HAS COMMITTED AN ANTI-DOPING RULE VIOLATION (ADRV) UNDER ARTICLE 2.1 OF THE IRONMAN ANTI-DOPING RULES (IRONMAN ADR) FOR THE PRESENCE OF PREDNISOLONE AND PREDNISONE IN A SAMPLE COLLECTED IN-COMPETITION BY IRONMAN ON 25 NOVEMBER 2022 IN THE SCOPE OF THE 2022 IRONMAN ISRAEL. VINCENZO TOMASELLO PARTICIPATED IN THE EVENT IN THE AGE GROUP CATEGORY.
The sample collected from Vincenzo Tomasello returned an adverse analytical finding for the specified prohibited substances prednisolone and prednisone. Both substances are prohibited in-competition only and when administered via specific routes under the World Anti-Doping Agency’s Prohibited List as glucocorticoids (S9). Glucocorticoids are used for pain-relief and anti-inflammation.
After review of the case file, the ITA found that a fourteen (14) month period of ineligibility pursuant to article 10.6.1.1. IRONMAN ADR1 and disqualification of results from the 2022 IRONMAN Israel (25 November 2022) going forward were the applicable consequences. Mr Vincenzo accepted the consequences proposed by the ITA and the case was resolved via an acceptance of consequences pursuant to article 8.3.1 of the IRONMAN ADR. Since the athlete had accepted a voluntary provisional suspension pending the resolution of his case, the athlete’s period of ineligibility across all sports runs until 26 May 2024.
Following the launch of the sample re-analysis program for the Olympic Games Rio 2016, the ITA reports that the re-analysis of a sample collected from athlete Christos Volikakis has returned an Adverse Analytical Finding¹ for SARMS LGD-4033 metabolite, a non-specified prohibited substance according to the Prohibited List of the World Anti-Doping Agency (WADA).
The sample was collected by the IOC during an in-competition anti-doping control performed on 16 August 2016 during the cycling track sprint event at the Olympic Games Rio 2016. The sample was first analysed during the Olympic Games Rio 2016 and was reported as negative with the detection methods applied by the WADA-accredited laboratory available at the time.
The athlete has been informed of the case. He has the right to request the analysis of the B-sample. If the B-sample analysis is requested and confirms the result of the A-sample, or if the B-sample analysis is not requested, the case will proceed as a confirmed anti-doping rule violation. The athlete has the opportunity to present his explanations for the positive result.
The matter will thereafter be referred to the Anti-Doping Division of the Court of Arbitration for Sport (CAS ADD) for adjudication under the IOC Anti-Doping Rules.
Given that the case is underway, there will be no further comments during the ongoing proceeding.
FROM 1 JANUARY 2024, TRAMADOL WILL BE PROHIBITED FROM IN-COMPETITION USE IN SPORT. DO YOU KNOW IF OR HOW THIS ADDITION TO THE PROHIBITED LIST MAY AFFECT YOU?
What is tramadol?
Tramadol is a synthetic opioid pain medication used to treat moderate-to-severe pain. It is sometimes used to treat pain due to sports injuries in athletes. It is in the category of “Narcotics” on the Prohibited List.
Tramadol is available in many different formulations, and is sold under many various brand names in different countries. Examples of brand names include: Tramal, Tramedo, Tramake, Zydol. Many other brand names exist and so athletes should check with their doctor or pharmacist what brands are prescribed in their own countries.
How does a substance get added to the Prohibited List?
For a substance to be placed on the Prohibited List it must meet two of the three following criteria:
- It has the potential to enhance or enhances performance
- It represents and actual or potential health risk to the athlete
- It violates the spirit of sport
Which criteria does tramadol meet?
Recent studies have confirmed the potential to enhance physical performance in certain activities. Read one of the studies here: Is tramadol a performance enhancing drug?
Tramadol use has potential health risks for athletes. It can result in serious side effects, which include addiction and physical dependence, seizures and decreased alertness.
Use of tramadol for the purpose of performance enhancement is also against the spirit of sport.
When is tramadol banned?
Athletes will be prohibited to use tramadol during the in-competition period unless they have a Therapeutic Use Exemption (TUE).
What is the In-Competition period?
The in-competition period usually begins at 11:59pm on the night before competition, but always check your International Federation’s (IF) Anti-Doping Rules.
Use of tramadol for urgent or emergency treatment of pain
Sometimes tramadol is required to be prescribed and administered to athletes for the urgent or emergency treatment of pain, such as when a severe, painful injury occurs during sport. When required for urgent or emergency treatment during the in-competition period, a Retroactive TUE should be applied for. It is therefore important that your doctor keeps good medical records of tramadol administration as it will be needed for this purpose.
I’m an athlete and I sometimes take tramadol for pain: what do I need to do?
Tell your doctor that tramadol is banned in-competition in sport. Ask them to consider your treatment options and possible alternatives.
If you require tramadol for your condition, ask your doctor to support you in submitting a TUE application. This may be a “Retroactive TUE” if tramadol was needed urgently for emergency treatment.
Understand the process around TUEs and whether you need one. Make sure you follow the necessary steps and have the required medical documentation. The ITA Athlete Hub is an excellent resource for more information on these topics.
Consequences of taking prohibited substances
The consequences of a positive test for a substance on the Prohibited List can be wide-ranging, with potential serious adverse effects to your health, sanctions from competing in your sport which will impact your sporting career, social and family network and potentially your finances.
You can find two interesting webinars on the ITA YouTube channel about the consequences of doping. Check out this playlist, or watch them directly below.
The ITA’s partnership with Caribbean RADO focuses on harmonising testing efforts to ensure an effective allocation of resources and intelligence-led programs at both national and international levels. The collaboration also supports the exchange of information between the ITA and the Caribbean RADO to the benefit of potential investigations and intelligence-led doping controls in the countries and for the athletes it represents. Finally, the collaboration also extends to identifying mutual efficiencies and opportunities for capacity building in the area of anti-doping education.
The Caribbean Regional Anti-Doping Organization is based in Barbados and acts as the secretariat to coordinate anti-doping efforts in the countries of Antigua & Barbuda, Aruba, Barbados, Bonaire, British Virgin Islands, Cayman Islands, Curacao, Dominica, Grenada, Guyana, Montserrat, St. Lucia, St. Kitts and Nevis, St. Vincent and the Grenadines, Suriname, The Virgin Islands (US), Trinidad and Tobago and Turks and Caicos Islands. It was established in 2005, one year after the World Anti-Doping Agency (WADA) created the RADO program to strengthen the protection of athletes in regions where countries organise their anti-doping efforts within regional conglomerates and is one of three RADOs in the Americas. It is the third RADO to enter a partnership with the ITA after the Central Asian and Panamerican RADOs.
“We are very pleased to officialise our collaboration with the Caribbean RADO and strengthen our network of partnerships in the Americas,” said ITA Director General Benjamin Cohen. “Through our joint agreement we can work hand in hand to enhance anti-doping efforts for international-level athletes from the countries the Caribbean RADO represents and those who are tested within their territory. Seamless information-sharing between our two organisations will furthermore ensure that investigations into any potential doping offences can be conducted across borders and regions. I welcome the Caribbean RADO to our network of partnerships with national and regional anti-doping organisations and look forward to working with them for our joint cause of fair play and clean sport.”
“The Caribbean Regional Anti-Doping Organization is committed to fostering a clean-sport environment, ensuring that our member countries are compliant with the World Anti-Doping Code, while protecting the rights of athletes,” said Patrick Werleman, Chairman of the Caribbean Regional Anti-Doping Organization. “As such, we focus on establishing key partnerships with regional and international organizations. We are enthusiastic about the new collaboration agreement between the Caribbean RADO and the International Testing Agency (ITA). We have worked well with the ITA on numerous occasions; and this MOU further highlights our continued commitment to the delivery of high-quality anti-doping services. The Caribbean RADO coordinates most of the sample collection in our member countries on behalf of local, regional, and international sporting bodies. This collaboration with the ITA is especially valuable in the areas of testing, information sharing and intelligence. We are looking forward to working closer and more effectively with the ITA to the benefit of our member countries and the Caribbean region as a whole.”
The ITA has already established bilateral collaboration agreements with over 30 National and Regional Anti-Doping Organisations on all continents of the world. The ITA strongly believes that the anti-doping community is able to bring the support of athletes to the next level by working hand-in-hand with all other anti-doping organisations. Consequently, the ITA will continue to welcome to its network any National and Regional Anti-Doping Organisation that wishes to strengthen synergies between national and international level anti-doping programs.
THE INTERNATIONAL TESTING AGENCY (ITA) REPORTS THAT THE SRI LANKAN RIDER MATHILDA KARLSSON HAS BEEN SANCTIONED WITH A 19-MONTH PERIOD OF INELIGIBILITY AFTER MISSING THREE ANTI-DOPING CONTROLS WITHIN A TWELVE-MONTH PERIOD.
The ITA, on behalf of the Fédération Équestre Internationale (FEI), confirms that Mathilda Karlsson has been suspended for a 19-month period, effective until 14 January 2025 after committing three whereabouts failures within a twelve-month period as defined in article 2.4 of the FEI ADRHA.
The case was resolved via an agreement on consequences pursuant to article 8.3.1 of the FEI Anti-Doping Rules for Human Athletes (FEI ADRHA), and equivalent provision in the World Anti-Doping Code.
The athlete qualified for a reduction of the otherwise two-year period ineligibility pursuant to article 10.3.2 of the FEI ADRHA which provides that the sanction can be reduced to a minimum of one year depending on the athlete’s degree of fault. The athlete’s results will be disqualified from 20 November 2022 until the start of the athlete’s provisional suspension on 15 June 2023.
Lausanne (RWH) The coming webinar of the International Testing Agency ITA will address the wider topic of integrity in sport with a focus on competition manipulation.
THE INTERNATIONAL TESTING AGENCY (ITA) REPORTS THAT A SAMPLE COLLECTED FROM EL HASSAN EL ABBASSI, RUNNER FROM BAHRAIN, HAS RETURNED AN ADVERSE ANALYTICAL FINDING (“AAF”) FOR HOMOLOGOUS BLOOD TRANSFUSION (M.1 PROHIBITED METHOD - MANIPULATION OF BLOOD).
THE INTERNATIONAL TESTING AGENCY (ITA), LEADING AN INDEPENDENT ANTI-DOPING PROGRAM FOR THE INTERNATIONAL WEIGHTLIFTING FEDERATION (IWF), PROVIDES AN UPDATE ON TWO ANTI-DOPING RULE VIOLATIONS FOR WEIGHTLIFTERS ARLEY MENDEZ PEREZ (CHILE) AND ROSA FIGUEIREDO (BRAZIL), BOTH QUALIFIED FOR THE TOKYO GAMES.
The International Testing Agency (ITA) asks the International Weightlifting Federations’ (IWF’s) Independent Panel to impose sanctions on the Federación Colombiana de Levantamiento de Pesas under the IWF Anti-Doping Rules and the IWF Qualification System for the Olympic Games Tokyo 2020, as a consequence of numerous Anti-Doping Rule Violations.
Lausanne, Switzerland, 23 September 2020 – The World Squash Federation (WSF) will delegate its entire anti-doping program to the International Testing Agency in January 2021, including results management and the development of an education plan for its athletes.
Global Summit 2024